federal_register: 2019-25986

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2019-25986 Adaptive Designs for Clinical Trials of Drugs and Biologics; Guidance for Industry; Availability Notice The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Adaptive Designs for Clinical Trials of Drugs and Biologics." This guidance provides guidance to sponsors and applicants submitting investigational new drug applications (INDs), new drug applications (NDAs), biologics license applications (BLAs), or supplemental applications on the appropriate use of adaptive designs for clinical trials to provide evidence of the effectiveness and safety of a drug or biological product. The guidance describes important principles for designing, conducting, and reporting the results from an adaptive clinical trial. This guidance finalizes the draft guidance entitled "Adaptive Designs for Clinical Trials of Drugs and Biologics" issued in October 2018. FDA is also announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. 2019-12-02 2019 12 https://www.federalregister.gov/documents/2019/12/02/2019-25986/adaptive-designs-for-clinical-trials-of-drugs-and-biologics-guidance-for-industry-availability https://www.govinfo.gov/content/pkg/FR-2019-12-02/pdf/2019-25986.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Adaptive Designs for Clinical Trials of Drugs and Biologics." This guidance provides guidance to sponsors and applicants...

Links from other tables